.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Notably, the Mumbai-based nutrition startup TruNativ recently secured approximately $30 million (about Rs 283.5 crore) in its Series B funding round. Crucially, the global healthcare investment firm OrbiMed led this capital infusion. Consequently, this major investment highlights why preventive nutrition is now a critical clinical priority in India.
Historically, Indian consumers have remained severely underserved by typical dietary options. Specifically, many modern products promise health benefits but deliver unhealthy compromises, leading to widespread protein deficiencies. Furthermore, local populations face massive overexposure to refined sugars. Therefore, TruNativ developed clean-label products to address these daily clinical gaps in Indian households. Subsequently, OrbiMed senior executives Sunny Sharma and Sumona Chakraborty will join TruNativ’s board. As a result, the startup will combine strong corporate governance with a clear medical focus.
Indeed, the Mumbai-based company will utilize the newly raised capital to expand its nationwide distribution network. Specifically, this expansion will cover direct-to-consumer platforms, quick commerce, modern trade, and pharmacies. Additionally, TruNativ will deploy significant resources to scale its B2B2C ingredient business. Currently, this segment supplies science-backed nutrition solutions to several major consumer brands in India. Thus, doctors can expect a higher availability of healthier alternatives across various therapeutic categories. In addition, the brand plans to establish a new research and development center to drive medical food innovation.
Essentially, TruNativ operates across high-growth nutrition sectors including sugar substitutes, proteins, gut health, and beauty wellness. Since then, the company has focused on providing clean-label products. For instance, these products help patients manage diabetes risks and improve gastrointestinal function. Consequently, doctors can recommend these science-backed dietary choices to support ongoing therapeutic interventions. Ultimately, this significant capital injection will accelerate the accessibility of preventive healthcare options throughout India.
Q1: Who led the Series B funding round for TruNativ?
OrbiMed, a leading global healthcare investment firm, led the $30 million Series B funding round for TruNativ.
Q2: What are the main product categories offered by TruNativ?
TruNativ operates across key preventive nutrition areas, including sugar alternatives, protein supplements, gut health, and beauty wellness products.
Q3: How will TruNativ utilize the newly raised Series B funds?
The company will use the funds to expand its retail and pharmacy distribution network, grow its B2B2C ingredient division, and build a new R&D center.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Mumbai-based startup TruNativ has raised $30 million in a Series B round led by OrbiMed. This investment highlights the growing importance of clean-label, nutrition-focused products to tackle India's widespread protein deficiency and sugar overexposure.
4 months ago
Kenya's confirmation of its eighth Ebola infection highlights the acute risk of secondary transmission in hospital environments. Clinicians must maintain high vigilance, enforce strict infection prevention protocols, and implement rapid triage mechanisms for viral hemorrhagic fevers across healthcare settings.
3 days back
Maternal anaemia contributes to nearly half of pregnancy-related fatalities across India. To prevent complications, Uttar Pradesh has added single-dose parenteral iron to its essential medicines list. This clinical transition aims to restore haemoglobin rapidly and protect high-risk mothers across rural facilities.
Last week
India's food safety authority FSSAI has issued show-cause notices to Gemini Edibles, BigBasket, and Flipkart for unpermitted cardiovascular claims regarding Freedom Rice Bran Oil. This regulatory move highlights the strict enforcement of advertising standards and the clinical necessity of evidence-based lipid care.
5 days back
The state government is deploying helicopter emergency medical services across the Mumbai-Pune Expressway, Samruddhi Mahamarg, and Mumbai-Goa Highway. This initiative establishes unified standard operating procedures to enable rapid triage, advanced prehospital resuscitation, and seamless trauma care transfers.
Last week
Atherosclerotic cardiovascular disease guidelines often rely on European-derived lipoprotein(a) cutoffs. However, baseline Lp(a) levels vary widely across ancestries, including South Asians and Africans. Clinicians must interpret Lp(a) values within overall absolute cardiovascular risk.
Last week
